000 00991 a2200277 4500
005 20250517005427.0
264 0 _c20160906
008 201609s 0 0 eng d
022 _a1759-4820
024 7 _a10.1038/nrurol.2014.334
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLabrie, Fernand
245 0 0 _aProstate cancer: Bicalutamide dose increase in castration-resistant disease.
_h[electronic resource]
260 _bNature reviews. Urology
_cMar 2015
300 _a132-3 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aAndrogen Antagonists
_xtherapeutic use
650 0 4 _aAnilides
_xtherapeutic use
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aOrchiectomy
650 0 4 _aProstatic Neoplasms
_xdrug therapy
773 0 _tNature reviews. Urology
_gvol. 12
_gno. 3
_gp. 132-3
856 4 0 _uhttps://doi.org/10.1038/nrurol.2014.334
_zAvailable from publisher's website
999 _c24439821
_d24439821